160 related articles for article (PubMed ID: 19135498)
1. Chemical and toxicological characterization of commercial smokeless tobacco products available on the Canadian market.
Rickert WS; Joza PJ; Trivedi AH; Momin RA; Wagstaff WG; Lauterbach JH
Regul Toxicol Pharmacol; 2009 Mar; 53(2):121-33. PubMed ID: 19135498
[TBL] [Abstract][Full Text] [Related]
2. Surveillance of moist snuff: total nicotine, moisture, pH, un-ionized nicotine, and tobacco-specific nitrosamines.
Richter P; Hodge K; Stanfill S; Zhang L; Watson C
Nicotine Tob Res; 2008 Nov; 10(11):1645-52. PubMed ID: 18988077
[TBL] [Abstract][Full Text] [Related]
3. Decreased levels of tobacco-specific N-nitrosamines in moist snuff on the Swedish market.
Osterdahl BG; Jansson C; Paccou A
J Agric Food Chem; 2004 Aug; 52(16):5085-8. PubMed ID: 15291479
[TBL] [Abstract][Full Text] [Related]
4. Changing smokeless tobacco products new tobacco-delivery systems.
Hatsukami DK; Ebbert JO; Feuer RM; Stepanov I; Hecht SS
Am J Prev Med; 2007 Dec; 33(6 Suppl):S368-78. PubMed ID: 18021912
[TBL] [Abstract][Full Text] [Related]
5. A qualitative and quantitative risk assessment of snuff dipping.
Nilsson R
Regul Toxicol Pharmacol; 1998 Aug; 28(1):1-16. PubMed ID: 9784428
[TBL] [Abstract][Full Text] [Related]
6. Applying toxicological risk assessment principles to constituents of smokeless tobacco products: implications for product regulation.
Ayo-Yusuf OA; Connolly GN
Tob Control; 2011 Jan; 20(1):53-7. PubMed ID: 20924040
[TBL] [Abstract][Full Text] [Related]
7. Free nicotine content and strategic marketing of moist snuff tobacco products in the United States: 2000-2006.
Alpert HR; Koh H; Connolly GN
Tob Control; 2008 Oct; 17(5):332-8. PubMed ID: 18669556
[TBL] [Abstract][Full Text] [Related]
8. Chemical and toxicological characteristics of conventional and low-TSNA moist snuff tobacco products.
Song MA; Marian C; Brasky TM; Reisinger S; Djordjevic M; Shields PG
Toxicol Lett; 2016 Mar; 245():68-77. PubMed ID: 26802282
[TBL] [Abstract][Full Text] [Related]
9. Supping with the devil? The role of law in promoting tobacco harm reduction using low nitrosamine smokeless tobacco products.
Hall W; Gartner C
Public Health; 2009 Mar; 123(3):287-91. PubMed ID: 19223052
[TBL] [Abstract][Full Text] [Related]
10. The chemical composition of smokeless tobacco: a survey of products sold in the United States in 2006 and 2007.
Borgerding MF; Bodnar JA; Curtin GM; Swauger JE
Regul Toxicol Pharmacol; 2012 Dec; 64(3):367-87. PubMed ID: 23000415
[TBL] [Abstract][Full Text] [Related]
11. Tobacco-specific nitrosamines in new tobacco products.
Stepanov I; Jensen J; Hatsukami D; Hecht SS
Nicotine Tob Res; 2006 Apr; 8(2):309-13. PubMed ID: 16766423
[TBL] [Abstract][Full Text] [Related]
12. Harmful and potentially harmful constituents (HPHCs) in two novel nicotine pouch products in comparison with regular smokeless tobacco products and pharmaceutical nicotine replacement therapy products (NRTs).
Back S; Masser AE; Rutqvist LE; Lindholm J
BMC Chem; 2023 Mar; 17(1):9. PubMed ID: 36869349
[TBL] [Abstract][Full Text] [Related]
13. Surveillance of smokeless tobacco nicotine, pH, moisture, and unprotonated nicotine content.
Richter P; Spierto FW
Nicotine Tob Res; 2003 Dec; 5(6):885-9. PubMed ID: 14668072
[TBL] [Abstract][Full Text] [Related]
14. The composition of contemporary American and Swedish smokeless tobacco products.
McAdam KG; Kimpton H; Faizi A; Porter A; Rodu B
BMC Chem; 2019 Dec; 13(1):31. PubMed ID: 31384779
[TBL] [Abstract][Full Text] [Related]
15. The nicotine market: an attempt to estimate the nicotine intake from various sources and the total nicotine consumption in some countries.
Fagerström K
Nicotine Tob Res; 2005 Jun; 7(3):343-50. PubMed ID: 16085502
[TBL] [Abstract][Full Text] [Related]
16. Alternative forms of tobacco use.
Prignot JJ; Sasco AJ; Poulet E; Gupta PC; Aditama TY
Int J Tuberc Lung Dis; 2008 Jul; 12(7):718-27. PubMed ID: 18544194
[TBL] [Abstract][Full Text] [Related]
17. Tobacco smoke: unraveling a controversial subject.
Thielen A; Klus H; Müller L
Exp Toxicol Pathol; 2008 Jun; 60(2-3):141-56. PubMed ID: 18485684
[TBL] [Abstract][Full Text] [Related]
18. Determination of nicotine, pH, and moisture content of six U.S. commercial moist snuff products--Florida, January-February 1999.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1999 May; 48(19):398-401. PubMed ID: 10366135
[TBL] [Abstract][Full Text] [Related]
19. Constituents in tobacco and smoke emissions from Canadian cigarettes.
Hammond D; O'Connor RJ
Tob Control; 2008 Sep; 17 Suppl 1():i24-31. PubMed ID: 18768456
[TBL] [Abstract][Full Text] [Related]
20. Free-base nicotine in tobacco products. Part II. Determination of free-base nicotine in the aqueous extracts of smokeless tobacco products and the relevance of these findings to product design parameters.
Lauterbach JH; Bao M; Joza PJ; Rickert WS
Regul Toxicol Pharmacol; 2011 Feb; 59(1):8-18. PubMed ID: 20849905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
